A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis

BACKGROUND: Psoriasis is an inflammatory systemic disease with a chronic relapsing course. Methotrexate, a dihydrofolate reductase inhibitor, and Apremilast, an oral phosphodiesterase type 4 inhibitor, are currently the mainstay drugs in the treatment of psoriasis. AIMS AND OBJECTIVES: To compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Divyanshu, Krishna, Arvind, David, Abhinav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564189/
https://www.ncbi.nlm.nih.gov/pubmed/37822410
http://dx.doi.org/10.4103/ijd.ijd_813_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564189/
https://www.ncbi.nlm.nih.gov/pubmed/37822410
http://dx.doi.org/10.4103/ijd.ijd_813_22

Ejemplares similares